summary
Introduced
01/07/2024
01/07/2024
In Committee
02/26/2024
02/26/2024
Crossed Over
Passed
Dead
03/08/2024
03/08/2024
Introduced Session
2024 Regular Session
Bill Summary
An act relating to the Department of Health; creating s. 381.991, F.S.; creating the Andrew John Anderson Pediatric Rare Disease Grant Program within the department for a specified purpose; subject to an appropriation by the Legislature, requiring the program to award grants for certain scientific and clinical research; specifying entities eligible to apply for the grants; specifying the types of applications that may be considered for grant funding; providing for a competitive, peer-reviewed application and selection process; providing that the remaining balance of appropriations for the program as of a specified date may be carried forward for a specified timeframe under certain circumstances; providing an effective date.
AI Summary
This bill creates the Andrew John Anderson Pediatric Rare Disease Grant Program within the Department of Health. The program, subject to annual legislative appropriation, will award grants for scientific and clinical research to further the search for new diagnostics, treatments, and cures for pediatric rare diseases. The grants will be awarded through a competitive, peer-reviewed process, with preference given to proposals that foster collaboration between institutions, researchers, and community practitioners. The bill establishes guidelines for ethical conduct and conflict of interest management for the review panels that will evaluate the grant applications. Additionally, any unspent but obligated funds from the program's appropriation can be carried forward for up to 5 years.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (3)
Other Sponsors (2)
Health & Human Services Committee (House), Health Care Appropriations Subcommittee (House)
Last Action
Laid on Table (on 03/05/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...